NCT05653661View on ClinicalTrials.gov

Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 30, 2024

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Melanoma
Interventions
PROCEDURE

Biopsy

Undergo tissue biopsies

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Computed Tomography

Undergo CT scans

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI scans

DRUG

Nab-paclitaxel/Danburstotug Complex AP160

Given IV

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05653661 - Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter